Member of Tentamus - Visit Tentamus.com

VelaLabs – Meaningful Analytics

Analytical Characterization of Biomolecules

VelaLabs is a world -wide acting, GMP-certified and GCLP-compliant contract laboratory that is the Tentamus specialist for in-depth analytical characterization services for proteins including biopharmaceuticals, biosimilars, biologics and peptides. Combining a focused, customer – orientated approach, a highly motivated team and a broad expertise in analytical development and quality control, VelaLabs is dedicated to support customer’s needs from research activities and clinical phases up to product commercialization and market release.

Philosophy

Our philosophy is to support our customers during the journey through the adventure of health.

With our help you have a competent partner in your side for the whole process of drug development that supports you with analytical development, clinical expertise and regulatory consulting.

VelaLabs stands for individual customer support, highest quality standards and professional expertise and we are an international partner for the pharma and biotechnology industry developing biopharmaceuticals and biosimilars.

Our solutions are not out-of-the-box and our flexible and dynamic team can provide tailored solutions for our customers while also having regulatory expertise.

GMP Certification

VelaLabs offers analytical test methods for medicinal drugs in the preclinical and clinical development phase. The analytical portfolio is based on International Conference for Harmonization (ICH) guidelines and covers non-cellular and cellular methods. The portfolio is further completed by advisory support for submission-relevant clinical studies and drug product release.

The most important tool for assuring the quality standards of VelaLabs is the GMP certification, which represents the highest level of quality in the pharmaceutical industry. Furthermore, VelaLabs is working compliant with GCLP guidelines for all bioanalytical services.

Memberships and Cooperation

VelaLabs collaborates with the St. Anna Children’s Hospital, which provides comprehensive care for the children and young people entrusted to them: The concept of the hospital integrates the treatment of patients according to the latest state of medical knowledge, care as support for self-care in close cooperation with caregivers and the psychosocial care of the patients and their families.

Auditreu provides controlling, accounting, tax consulting and payroll to VelaLabs.

VelaLabs is member of Life Science Austria Vienna Region (LISA VR), which provides support and advice to start-ups and high-technology companies.

Vela is partner of the network and cluster of Human Technology Styria.

Biomedica is a leading distributor of medical devices, in-vitro diagnostics and products for Life Sciences. VelaLabs and Biomedica collaborate regarding the implementation, use, marketing and testing services of the GlycoTechnica LecChip technology.

Evercyte offers immortalized cells that retain their primary-like human cell characteristics. VelaLabs and Evercyte have a cooperation for the usage of immortalized cell lines for biosimilar characterization.

Long-term partners of VelaLabs are the Department of Clinical Pharmacology and the Coordination Center for Clinical Studies (KKS) both from the Medical University of Vienna.

BLS – Analytik GmbH & co. KG is a Tentamus laboratory, focusing on the physical, physical-chemical and chemical testing and analysis of pharmaceuticals, food, feed and cosmetic products. BLS is a fully GMP, FDA, and ISO 17025 inspected and approved laboratory.

BAV Institute is an accredited contract laboratory offering hygiene and quality control services in the fields of food, cosmetics, and pharma. In addition to microbial testing, the company specializes in on-site consulting and training.

Protagen Protein Services (PPS) is a leading CRO in protein analytics and its application to GMP-compliant characterization of protein therapeutics. PPS supports multiple biosimilar developers in achieving and demonstrating biosimilarity. Many years of experience of PPS in business and a comprehensive spectrum of validated analytical methods ensure highest quality for customers in the pharmaceutical, biotechnology and life science industry.

Analytical Services provides fully GMP-compliant analytical services and is a FDA registered laboratory. Analytical Services is a partner for orthogonal methods, which are not established at VelaLabs.

MPL Mikrobiologisches Prüflabor GmbH is the GMP certified partner of VelaLabs for microbiological analytics.

Customers

VelaLabs’s customers include some of the biggest names in Pharma and Biotech. Our focused, customer – orientated approach, a highly motivated team and a broad expertise in analytical development and quality control led to a trusting relationship that has met the requirements of our customers for over 10 years.

Pharma

Biotech

Read all news

Cannabinoid Testing in Cosmetics

Adamson Analytical Laboratories – Your trusted partner for testing your CBD Beauty & Cosmetic products Since AAL became a member of the Tentamus network, a number of improvements have been made in the facility. Some of these updates include various renovations of the laboratory as well as construction of new rooms inside the facility, the ... Continued

FDAS goes online with new website

FDAS – A Tentamus Company, is pleased to announce its new website.   Founded in 2004, FDAS is a leading independent contract laboratory providing QC analysis to the Pharmaceutical, Medical Device and Herbal industries. Our new site provides our visitors an easier way to learn about FDAS, our services and our solutions to help get ... Continued

Tentamus Group acquires majority stake in Megsan Labs

Berlin (Germany)/ Hyderabad (India), June 24th 2019 Tentamus Group today announced that it has acquired a majority stake in the leading analytical testing services company to pharmaceutical companies, Megsan Labs (in Hyderabad, India). The acquisition is part of Tentamus’ plan to broaden its portfolio of services that support pharmaceutical and biotech customers globally and expand across ... Continued

Draft Guidance for Industry: Mitigation Strategies to Protect Food Against Intentional Adulteration – IA Rule Next Compliance date is July 26, 2019

This draft guidance is being distributed for comment purposes only; submit comments by 07/05/2019 (https://www.regulations.gov/document?D=FDA-2018-D-1398-0025). FSMA’s Mitigation Strategies to Protect Food Against Intentional Adulteration (IA Rule) requires both domestic and foreign companies that are required to register with the FDA to develop strategies that prevent intentional adulteration of food. Depending on business size, compliance dates ... Continued

Tentamus laboratories in your vicinity